Leighton C. Stein

494 total citations
18 papers, 397 citations indexed

About

Leighton C. Stein is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Leighton C. Stein has authored 18 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Leighton C. Stein's work include Gene expression and cancer classification (5 papers), Molecular Biology Techniques and Applications (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Leighton C. Stein is often cited by papers focused on Gene expression and cancer classification (5 papers), Molecular Biology Techniques and Applications (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Leighton C. Stein collaborates with scholars based in United States and Ukraine. Leighton C. Stein's co-authors include Lesleyann Hawthorn, John K. Cowell, М.D. Тronko, Thom R. Loree, Bogdanova Ti, Geraldine Thomas, Wiam Bshara, Heinz Baumann, Gregory Loewen and Thaer Khoury and has published in prestigious journals such as Blood, Clinical Cancer Research and Oncotarget.

In The Last Decade

Leighton C. Stein

17 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leighton C. Stein United States 10 207 132 111 97 65 18 397
Chiara Pesenti Italy 14 175 0.8× 105 0.8× 130 1.2× 81 0.8× 33 0.5× 24 405
Mariangela Balistreri Italy 10 270 1.3× 124 0.9× 219 2.0× 89 0.9× 40 0.6× 15 487
Ceren Gönen Korkmaz Norway 10 226 1.1× 84 0.6× 82 0.7× 142 1.5× 49 0.8× 14 450
PengXin Zhang China 9 261 1.3× 97 0.7× 55 0.5× 54 0.6× 46 0.7× 31 386
Jung-Ah Hwang South Korea 15 279 1.3× 152 1.2× 128 1.2× 140 1.4× 24 0.4× 23 447
Hengyu Lu United States 8 158 0.8× 111 0.8× 51 0.5× 55 0.6× 52 0.8× 11 269
Mai Tomiguchi Japan 12 280 1.4× 146 1.1× 272 2.5× 80 0.8× 29 0.4× 24 490
Boris Freydin United States 10 241 1.2× 274 2.1× 117 1.1× 34 0.4× 32 0.5× 17 470
Tomasz Tyszkiewicz Poland 11 180 0.9× 70 0.5× 99 0.9× 52 0.5× 32 0.5× 20 319
Emanuela Minna Italy 9 230 1.1× 85 0.6× 152 1.4× 74 0.8× 68 1.0× 12 392

Countries citing papers authored by Leighton C. Stein

Since Specialization
Citations

This map shows the geographic impact of Leighton C. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leighton C. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leighton C. Stein more than expected).

Fields of papers citing papers by Leighton C. Stein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leighton C. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leighton C. Stein. The network helps show where Leighton C. Stein may publish in the future.

Co-authorship network of co-authors of Leighton C. Stein

This figure shows the co-authorship network connecting the top 25 collaborators of Leighton C. Stein. A scholar is included among the top collaborators of Leighton C. Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leighton C. Stein. Leighton C. Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Yamauchi, Takayoshi, Hidehito Saito, Takaaki Oba, et al.. (2023). Unraveling Tumorigenicity in iPSC-Derived Immune Cells: The Impact of Chromosomal Abnormalities and Proliferative Intermediates. Blood. 142(Supplement 1). 2081–2081.
3.
Abdou, Yara, Kristopher Attwood, Song Yao, et al.. (2020). Racial differences in CD8+ T cell infiltration in breast tumors from Black and White women. Breast Cancer Research. 22(1). 62–62. 32 indexed citations
4.
Omilian, Angela R., Gary Zirpoli, Ting‐Yuan David Cheng, et al.. (2019). Storage Conditions and Immunoreactivity of Breast Cancer Subtyping Markers in Tissue Microarray Sections. Applied immunohistochemistry & molecular morphology. 28(4). 267–273. 8 indexed citations
5.
Singh, Anurag K., Mohammad Habiby Kermany, Austin Miller, et al.. (2017). A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma. Clinical Cancer Research. 23(17). 5055–5065. 65 indexed citations
6.
Wang, Steven J., Saurabh Asthana, Annemieke van Zante, et al.. (2017). Establishment and characterization of an oral tongue squamous cell carcinoma cell line from a never-smoking patient. Oral Oncology. 69. 1–10. 9 indexed citations
8.
Ailawadhi, Sikander, Dongliang Wang, Taimur Sher, et al.. (2011). Bortezomib mitigates adverse prognosis conferred by Bcl-2 overexpression in patients with relapsed/refractory multiple myeloma. Leukemia & lymphoma. 53(6). 1174–1182. 17 indexed citations
9.
Hawthorn, Lesleyann, et al.. (2010). Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast. BMC Cancer. 10(1). 460–460. 41 indexed citations
10.
Stein, Leighton C., John K. Cowell, Geraldine Thomas, et al.. (2009). Copy Number and Gene Expression Alterations in Radiation-Induced Papillary Thyroid Carcinoma from Chernobyl Pediatric Patients. Thyroid. 20(5). 475–487. 71 indexed citations
11.
Chitta, Kasyapa S., Kiersten Marie Miles, Pushpankur Ghoshal, et al.. (2009). At-101 Induces Apoptosis Waldenstrom Macroglobulinemia Cells Resistant to Bortezomib.. Blood. 114(22). 2861–2861. 4 indexed citations
12.
Ghoshal, Pushpankur, Kasyapa S. Chitta, Slavoljub Vujcic, et al.. (2009). Mapatumumab, A TRAIL Receptor 1 Agonist Antibody, Induces Apoptosis in Bortezomib Resistant Multiple Myeloma.. Blood. 114(22). 2832–2832. 3 indexed citations
13.
Chitta, Kasyapa S., Pushpankur Ghoshal, Kiersten Marie Miles, et al.. (2009). Induced Resistance to Bortezomib in Preclinical Model of Waldenstrom Macroglobulinemia Is Associated with Bcl-2 Upregulation.. Blood. 114(22). 4919–4919. 4 indexed citations
14.
Stein, Leighton C., et al.. (2008). Universal Reference RNA is Not a Representative Normal Sample for Oligonucleotide Microarray Studies. Pathology & Oncology Research. 14(3). 243–251. 3 indexed citations
16.
Stein, Leighton C., et al.. (2007). An exfoliation and enrichment strategy results in improved transcriptional profiles when compared to matched formalin fixed samples. BMC Clinical Pathology. 7(1). 7–7. 7 indexed citations
17.
Hawthorn, Lesleyann, et al.. (2006). Characterization of cell-type specific profiles in tissues and isolated cells from squamous cell carcinomas of the lung. Lung Cancer. 53(2). 129–142. 37 indexed citations
18.
Hawthorn, Lesleyann, et al.. (2004). TIMP1 and SERPIN‐A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma. Head & Neck. 26(12). 1069–1083. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026